Anti-Proliferative Activity of Ethanol Extracts from Taxilli Ramulus (Taxillus chinensis (DC.) Danser) Through Cyclin D1 Proteasomal Degradation in Human Colorectal Cancer Cells |
Park, Gwang Hun
(Forest Medicinal Resources Research Center, National Institute of Forest Science)
Song, Hun Min (Department of Medicinal Plant Resources, Andong National University) Park, Su Bin (Department of Medicinal Plant Resources, Andong National University) Park, Ji Hye (Department of Medicinal Plant Resources, Andong National University) Shin, Myeong Su (Department of Medicinal Plant Resources, Andong National University) Son, Ho-Jun (Forest Medicinal Resources Research Center, National Institute of Forest Science) Um, Yurry (Forest Medicinal Resources Research Center, National Institute of Forest Science) Jeong, Jin Boo (Department of Medicinal Plant Resources, Andong National University) |
1 | Eo, H.J., G.H. Park, H.M. Song, J.W. Lee, M.K. Kim, M.H. Lee, J.R. Lee, J.S. Koo and J.B. Jeong. 2015. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. Int. Immunopharmacol. 24:1-6. DOI |
2 | Gillett, C., V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes and G. Peters. 1994. Amplification and over-expression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54:1812-1817. |
3 | Holland, T.A., J. Elder, J.M. McCloud, C. Hall, M. Deakin, A.A. Fryer, J.B. Elder and P.R. Hoban. 2001. Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival. Int. J. Cancer 95:302-306. DOI |
4 | Kato, A., A. Naiki-Ito, T. Nakazawa, K. Hayashi, I. Naitoh, K. Miyabe, S. Shimizu, H. Kondo, Y. Nishi, M. Yoshida, S. Umemura, Y. Hori, T. Mori, M. Tsutsumi, T. Kuno, S. Suzuki, H. Kato, H. Ohara, T. Joh and S. Takahashi. 2015. Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3beta and ERK1/2. Oncotarget 6:42963-42975. |
5 | Kim, M.K., G.H. Park, H.J. Eo, H.M. Song, J.W. Lee, M.J. Kwon, J.S. Koo and J.B. Jeong. 2015. Tanshinone I induces cyclin D1 proteasomal degradation in an ERK1/2 dependent way in human colorectal cancer cells. Fitoterapia 101: 162-168. DOI |
6 | Lee, S.H., M. Cekanova and S.J. Baek. 2008. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol. Carcino-genesis 47:197-208. DOI |
7 | Mermelshtein, A., A. Gerson, S. Walfisch, B. Delgado, G. Shechter-Maor, J. Delgado, A. Fich and L. Gheber. 2005. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Brit. J. Cancer 93:338-345. DOI |
8 | Park, G.H., H.M. Song and J.B. Jeong. 2016a. The coffee diterpene kahweol suppresses the cell proliferation by inducing cyclin D1 proteasomal degradation via ERK1/2, JNK and GKS3beta-dependent threonine-286 phosphorylation in human colorectal cancer cells. Food Chem. Toxicol. 95:142-148. DOI |
9 | Musgrove, E.A., C.E. Caldon, J. Barraclough, A. Stone and R.L. Sutherland. 2011. Cyclin D as a therapeutic target in cancer. Nat. Rev. Cancer 11:558-572. DOI |
10 | Okabe, H., S.H. Lee, J. Phuchareon, D.G. Albertson, F. McCormick and O. Tetsu. 2006. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS One 1:e128. DOI |
11 | Siegel, R.L., K.D. Miller, S.A. Fedewa, D.J. Ahnen, R.G.S. Meester, A. Barzi and A. Jemal. 2017. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 67:177-193. DOI |
12 | Park, G.H., J.H. Sung, H.M. Song and J.B. Jeong. 2016b. Anti-cancer activity of Psoralea fructus through the down-regulation of cyclin D1 and CDK4 in human colorectal cancer cells. BMC Complement. Altern. Med. 16:373. DOI |
13 | Park, G.H., S.C. Hong and J.B. Jeong. 2016c. Anticancer activity of the safflower seeds (Carthamus tinctorius L.) through inducing cyclin D1 proteasomal degradation in human colorectal cancer cells. Korean J. Plant Res. 29(3): 297-304. DOI |
14 | Russell, A., M.A. Thompson, J. Hendley, L. Trute, J. Armes and D. Germain. 1999. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 18:1983-1991. DOI |
15 | Thoms, H.C., M.G. Dunlop and L.A. Stark. 2007. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67:1660-1669. DOI |
16 | Casanovas, O., F. Miro, J.M. Estanyol, E. Itarte, N. Agell and O. Bachs. 2000. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275:35091-35097. DOI |
17 | Alao, J.P. 2007. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6:24. |
18 | Alt, J.R., J.L. Cleveland, M. Hannink and J.A. Diehl. 2000. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:3102-3114. DOI |
19 | Bahnassy, A.A., A.R. Zekri, S. El-Houssini, A.M. El-Shehaby, M.R. Mahmoud, S. Abdallah and M. El-Serafi. 2004. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 23:22-24. |
20 | Baker, D.D., M. Chu, U. Oza and V. Rajgarhia. 2007. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep. 24:1225-1244. DOI |
21 | Cragg, G.M., D.J. Newman and K.M. Snader. 1997. Natural products in drug discovery and development. J. Nat. Prod. 60:52-60. DOI |
22 | Diehl, J.A., M. Cheng, M.F. Roussel and C.J. Sherr. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511. DOI |
23 | Zhang, L., A.S. Ravipati, S.R. Koyyalamudi, S.C. Jeong, N. Reddy, P.T. Smith, J. Bartlett, K. Shanmugam, G. Munch and M.J. Wu. 2011. Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. J. Agric. Food Chem. 59:12361-12367. DOI |
24 | Wang, Y., M. Deng, S.Y. Zhang, Z.K. Zhou and W.X. Tian. 2008. Parasitic loranthus from Loranthaceae rather than Viscaceae potently inhibits fatty acid synthase and reduces body weight in mice. J. Ethnopharmacol. 118:473-478. DOI |
25 | Wen, C.C., L.F. Shyur, J.T. Jan, P.H. Liang, C.J. Kuo, P. Arulselvan, J.B. Wu, S.C. Kuo and N.S. Yang. 2011. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J. Trad. Complement. Med. 1:41-50. DOI |
26 | Woo, I.S. and Y.H. Jung. 2017. Metronomic chemotherapy in metastatic colorectal cancer. Cancer Lett. 400:319-324. DOI |
27 | Zhang, L., S.R. Koyyalamudi, S.C. Jeong, N. Reddy, T. Bailey and T. Longvah. 2013. Immunomodulatory activities of polysaccharides isolated from Taxillus chinensis and Uncaria rhyncophylla. Carbohydr. Polym. 98:1458-1465. DOI |